Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advocates for Arthritis Fly-In Event Benefits Rheumatology Patients

Kelly Tyrrell  |  September 9, 2018

“I want to be informed about healthcare so I can make good decisions for myself,” she says. “It’s fun to learn and be able to tell other people about it.”

Pitch In & Have Patience
The results of advocacy may not always manifest immediately, says Dr. Harvey, but “if we keep the message up over time, we can have an impact.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This is what continues to motivate Dr. Shakoory. “There is a huge need for advocacy, no matter which way you look at it, and we are approaching the lawmakers to try to change things for rheumatology patients. I think we all need to pitch in—every single one of us—in whatever capacity we can.”


Kelly April Tyrrell writes about health, science and health policy. She lives in Madison, Wis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

 

 

Page: 1 2 3 | Single Page
Share: 

Filed under:American College of RheumatologyLegislation & AdvocacyProfessional Topics Tagged with:Advocacy 101Advocates for ArthritisDepartment of Defense (DoD)dual-energy X-ray absorptiometry (DXA)step therapy

Related Articles
    Oksana Kuzmina/shutterstock.comx

    Environmental Factors in Pediatric Systemic Autoimmune Diseases

    March 20, 2017

    Systemic autoimmune diseases are thought to result from immune dysregulation in genetically susceptible individuals who were exposed to environmental risk factors. Many studies have identified genetic risk factors for these diseases, but concordance rates among monozygotic twins are 25–40%, suggesting that nonheritable environmental factors play a more prominent role.1,2 Through carefully conducted epidemiologic and other…

    What Adult Rheumatologists Need to Know about Juvenile Arthritis

    May 1, 2013

    How to recognize distinctions between pediatric and adult arthritis

    A Possible Diagnostic Tool: RheumMadness 2022 AI: JIA Subtypes Scouting Report

    February 14, 2022

    Machine learning is a tool that may help pediatric rheumatologists distinguish between different subtypes of juvenile idiopathic arthritis (JIA) and predict treatment response.

    Pursue Remission

    November 1, 2007

    Disease remission should be the goal for all rheumatologists treating childhood arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences